21-Oct-2016
Hindu Business Line
India and the US continued to differ on the issue of intellectual property rights (IPR) norms in their bilateral trade and investment policy discussions
13-Oct-2016
Don’t trade our lives away
Member countries must consider the impact of RCEP on access to medicines in developing countries
11-Oct-2016
South China Morning Post
Affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia
28-Sep-2016
Corporate Europe Observatory
Big Pharma is everything but shy when it comes to lobbying EU policy-makers. But what exactly are these groups lobbying for in TTIP?
20-May-2016
East Asia Forum
Of the RCEP negotiating countries, it is India, rather than China, that has been the most outspoken in opposing US-style trade rules.